Home » Stocks » TXAC

Therapeutics Acquisition Corporation (TXAC)

Aug 6, 2020 - Stock symbol was changed to RACA
Stock Price: $12.96 USD 0.00 (0.00%)
Updated Aug 6, 2020 4:00 PM EDT
Market Cap 232.31M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 14.04M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Aug 6, 2020
Last Price $12.96
Previous Close $12.96
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 12.21 - 13.10
Day's Volume 0
52-Week Range 11.11 - 21.44

News

Hide News
The Motley Fool - 6 months ago

These shell companies allow the businesses they acquire to go public much more quickly than an IPO would. Is it time to buy in?

Other stocks mentioned: INVA, JAZZ, TBPH, TXG
The Motley Fool - 7 months ago

Forget traditional IPOs! This blank check vehicle is proving to be an effective tool for biotech companies to raise capital.

Other stocks mentioned: IMVT, PHGE
Business Wire - 7 months ago

BOSTON--(BUSINESS WIRE)--Therapeutics Acquisition Corp. (Nasdaq: TXAC) (the “Company”) announced today that on July 10, 2020 it closed its initial public offering of 13,570,000 shares of Class...

The Motley Fool - 7 months ago

The special purpose acquisition company is sponsored by RA Capital Management.

About TXAC

Therapeutics Acquisition focuses on merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify and acquire a business focusing on the healthcare industry. The company was founded in 2020 and is based in Boston, Massachusetts.

Industry
Shell Companies
IPO Date
Jul 8, 2020
CEO
Peter Kolchinsky
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
TXAC
Full Company Profile